67 results on '"Castelo-Branco DSCM"'
Search Results
2. Antibiotics stimulates the development of persistent cells in biofilms of Candida albicans bloodstream isolates.
- Author
-
Portela FVM, Andrade ARC, Pereira LMG, da Silva BN, Peixoto PHS, Amando BR, Fiallos NM, Souza PFSM, Lima-Neto RG, Guedes GMM, Castelo-Branco DSCM, and Cordeiro RA
- Abstract
Candida albicans invasive candidiasis is considered a global health problem. In such cases, biofilm formation on implanted devices represents a therapeutic challenge and the presence of metabolically inactive persistent cells (PCs) in these communities increases their tolerance to fungicidal drugs. This study investigated the influence of amoxicillin, AMX; cefepime, CEF; gentamicin, GEN; amikacin, AMK; vancomycin, VAN; and ciprofloxacin, CIP; on the production of PCs in biofilms of C. albicans bloodstream isolates. 48 h-mature biofilms ( n = 6) grown in RPMI-1640 supplemented with antibiotics were treated with 100 μg ml
-1 amphotericin B and then evaluated for PCs. Biofilms grown in the presence of antibiotics produced more PCs, up to 10×, when exposed to AMX and CIP; 5 × to CEF; and 6 × to GEN and VAN. The results indicate that antibiotics can modulate PC production in C. albicans biofilms. This scenario may have clinical repercussions in immunocompromised patients under broad-spectrum antibiotic therapy.- Published
- 2024
- Full Text
- View/download PDF
3. Effect of the Combination of Synthetic Anthelmintics with Carvacryl Acetate in Emulsions with and without a Sodium Alginate Matrix on Haemonchus contortus .
- Author
-
Ximenes LF, Pinheiro HN, Filho JVA, André WPP, Abreu FOMDS, Cardial MRL, Castelo-Branco DSCM, Melo ACFL, Lopes FFDS, de Morais SM, de Oliveira LMB, and Bevilaqua CML
- Abstract
The present study aimed to evaluate the effect of nanoemulsions using combined synthetic anthelmintics, thiabendazole (TBZ), levamisole (LEV), and ivermectin (IVM), with carvacryl acetate (CA) against Haemonchus contortus , and also tested the presence and absence of alginate (ALG). The anthelmintic effect of the CA/TBZ nanoemulsion was evaluated in the egg hatch test (EHT). The effects of CA/IVM and CA/LEV nanoemulsions were evaluated in the larval development test (LDT). The emulsions CA/TBZ/ALG and CA/TBZ showed a multimodal profile, with most particles on the nanometric scale. The encapsulation efficiency in CA/TBZ/ALG was 80.25%, and that in CA/LEV/ALG was 89.73%. In the EHT, CA/TBZ and CA/TBZ/ALG showed mean combination indices (CIs) of 0.55 and 0.36, respectively, demonstrating synergism in both. In LDT, CA/IVM had an average CI of 0.75, and CA/LEV and CA/LEV/ALG showed CI values of 0.4 and 0.93, respectively. It was concluded that CA/TBZ showed a synergistic interaction, and CA/TBZ/ALG showed an enhanced effect. In addition, the matrix brought stability to the product, encouraging its improvement to obtain higher efficacy.
- Published
- 2024
- Full Text
- View/download PDF
4. Anthraquinones against Cryptococcus neoformans sensu stricto : antifungal interaction, biofilm inhibition and pathogenicity in the Caenorhabditis elegans model.
- Author
-
Araújo GDS, Brilhante RSN, Rocha MGD, Aguiar L, Castelo-Branco DSCM, Guedes GMM, Sidrim JJC, Pereira Neto WA, and Rocha MFG
- Subjects
- Animals, Antifungal Agents pharmacology, Caenorhabditis elegans, Itraconazole, Virulence, Anthraquinones pharmacology, Biofilms, Cryptococcus neoformans, Cryptococcosis, Anthracenes
- Abstract
Introduction. Cryptococcal biofilms have been associated with persistent infections and antifungal resistance. Therefore, strategies, such as the association of natural compounds and antifungal drugs, have been applied for the prevention of biofilm growth. Moreover, the Caenorhabditis elegans pathogenicity model has been used to investigate the capacity to inhibit the pathogenicity of Cryptococcus neoformans sensu stricto . Hypothesis. Anthraquinones and antifungals are associated with preventing C. neoformans sensu stricto biofilm formation and disrupting these communities. Antraquinones reduced the C. neoformans sensu stricto pathogenicity in the C. elegans model. Aim. This study aimed to evaluate the in vitro interaction between aloe emodin, barbaloin or chrysophanol and itraconazole or amphotericin B against growing and mature biofilms of C. neoformans sensu stricto . Methodology. Compounds and antifungal drugs were added during biofilm formation or after 72 h of growth. Then, the metabolic activity was evaluated by the MTT reduction assay, the biomass by crystal-violet staining and the biofilm morphology by confocal laser scanning microscopy. C. neoformans sensu stricto's pathogenicity was investigated using the nematode C. elegans . Finally, pathogenicity inhibition by aloe emodin, barbarloin and chrysophanol was investigated using this model. Results. Anthraquinone-antifungal combinations affected the development of biofilms with a reduction of over 60 % in metabolic activity and above 50 % in biomass. Aloe emodin and barbaloin increased the anti-biofilm activity of antifungal drugs. Chrysophanol potentiated the effect of itraconazole against C. neoformans sensu stricto biofilms. The C. elegans mortality rate reached 76.7 % after the worms were exposed to C. neoformans sensu stricto for 96 h. Aloe emodin, barbaloin and chrysophanol reduced the C. elegans pathogenicity with mortality rates of 61.12 %, 65 % and 53.34 %, respectively, after the worms were exposed for 96 h to C. neoformans sensu stricto and these compounds at same time. Conclusion. These results highlight the potential activity of anthraquinones to increase the effectiveness of antifungal drugs against cryptococcal biofilms.
- Published
- 2024
- Full Text
- View/download PDF
5. Antibiofilm activity of promethazine, deferiprone, and Manuka honey in an ex vivo wound model.
- Author
-
Guedes GMM, Freitas AS, Pinheiro RM, Pereira VC, Melgarejo CMA, de Araujo ES, Ribeiro KVC, Bandeira SP, Cordeiro RA, Rocha MFG, Sidrim JJC, and Castelo-Branco DSCM
- Subjects
- Animals, Swine, Promethazine pharmacology, Deferiprone pharmacology, Biofilms, Pseudomonas aeruginosa, Anti-Bacterial Agents pharmacology, Microbial Sensitivity Tests, Staphylococcus aureus, Honey
- Abstract
This study evaluated the antibiofilm activity of promethazine, deferiprone, and Manuka honey against Staphylococcus aureus and Pseudomonas aeruginosa in vitro and ex vivo in a wound model on porcine skin. The minimum inhibitory concentrations (MICs) and the effects of the compounds on biofilms were evaluated. Then, counting colony-forming units (CFUs) and confocal microscopy were performed on biofilms cultivated on porcine skin for evaluation of the compounds. For promethazine, MICs ranging from 97.66 to 781.25 µg/ml and minimum biofilm eradication concentration (MBEC) values ranging from 195.31 to 1562.5 µg/ml were found. In addition to reducing the biomass of both species' biofilms. As for deferiprone, the MICs were 512 and >1024 µg/ml, the MBECs were ≥1024 µg/ml, and it reduced the biomass of biofilms. Manuka honey had MICs of 10%-40%, MBECs of 20 to >40% and reduced the biomass of S. aureus biofilms only. Concerning the analyses in the ex vivo model, the compounds reduced (P < .05) CFU counts for both bacterial species, altering the biofilm architecture. The action of the compounds on biofilms in in vitro and ex vivo tests raises the possibility of using them against biofilm-associated wounds. However, further studies are needed to characterize the mechanisms of action and their effectiveness on biofilms in vivo., (© The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International.)
- Published
- 2023
- Full Text
- View/download PDF
6. β-Estradiol and progesterone enhance biofilm development and persister cell formation in monospecies and microcosms biofilms derived from vulvovaginal candidiasis.
- Author
-
Andrade ARC, Rezende MDS, Portela FVM, Pereira LMG, Nascimento da Silva B, Lima-Neto RG, Rocha MFG, Sidrim JJC, Castelo-Branco DSCM, and Cordeiro RA
- Abstract
The present study aimed to: (1) evaluate the influence of the steroid hormones (SH) on biofilm development; (2) investigate the formation of persister cells (PC) in biofilms; and (3) investigate the influence of SH on PC formation. Biofilms were derived from vulvovaginal candidiasis (VVC) samples and evaluated by three models: microcosm biofilms grown in Vaginal Fluid Simulator Medium (MiB-VFSM); monospecies biofilms grown in VFSM (MoB-VFSM) and RPMI media (MoB-RPMI). SH altered cell counting and biomass of biofilms grown in VSFM; MoB-RPMI were negatively affected by SH. SH stimulated the formation of PC in MiB-VFSM but not MoB-VFSM; MoB-RPMI showed a lower number of PC in the presence of SH. The results showed that SH altered the dynamics of biofilm formation and development, depending on the study model. The data suggest the influence of hormones on the physiology of Candida biofilms and reinforce the importance of PC in the pathogenesis of VVC.
- Published
- 2023
- Full Text
- View/download PDF
7. Standardization of in vitro dual-species biofilms of Staphylococcus pseudintermedius and Malassezia pachydermatis: a strategy to establish an ex vivo biofilm model.
- Author
-
Castelo-Branco DSCM, Aguiar L, Guedes GMM, Pereira-Neto WA, Cordeiro RA, Brilhante RSN, Sidrim JJC, and Rocha MFG
- Subjects
- Animals, Swine, Biofilms, Reference Standards, Staphylococcus, Malassezia
- Abstract
Ex vivo experiments have been performed aiming at mimicking in vivo environments. The main aim of this research was to standardize in vitro dual-species biofilm formation by Staphylococcus pseudintermedius and Malassezia pachydermatis as a strategy to establish an ex vivo biofilm model. Initially, the in vitro formation of biofilms in co-culture was established, using YPD medium, inoculum turbidity of 0.5 on the McFarland scale and maturation periods of 96 h for M. pachydermatis and 48 h for S. pseudintermedius. Subsequently, biofilms were formed on porcine skin using the same conditions, under which a greater number of cells/ml was observed in in vitro dual-species than in in vitro mono-species biofilms. Furthermore, ex vivo biofilm images demonstrated the formation of a highly structured biofilm with the presence of cocci and yeasts surrounded by the matrix. Thus, these conditions optimized the growth of both microorganisms within biofilms in vitro and ex vivo., Competing Interests: Declaration of Competing Interest We declare no conflicts of interest., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
8. Role of Brazilian bats in the epidemiological cycle of potentially zoonotic pathogens.
- Author
-
Castelo-Branco DSCM, Nobre JA, Souza PRH, Diógenes EM, Guedes GMM, Mesquita FP, Souza PFN, Rocha MFG, Sidrim JJC, Cordeiro RA, and Montenegro RC
- Subjects
- Animals, Humans, Brazil epidemiology, Zoonoses epidemiology, Phylogeny, Chiroptera, Viruses genetics, Rabies virus
- Abstract
Bats (Chiroptera) are flying mammals of great biodiversity and habits. These characteristics contribute for them being natural reservoirs and part of the epidemiological cycle of several potentially zoonotic pathogens, such as viruses, protozoa, fungi and bacteria. Brazil hosts approximately 15% of the world's bat diversity, with 181 distinct species, 68 genera and 9 families. About 60% of infectious diseases in humans are of zoonotic origin and, in the last decades, the detection of zoonotic pathogens in bats and their environment has been reported, such as Rabies virus (RABV) and Histoplasma capsulatum. Thus, the aim of this work was to review the reports of zoonotic pathogens associated with bats in Brazil in the past ten years. We reviewed the main pathogenic microorganisms described and the species of bats most frequently involved in the epidemiological cycles of these zoonotic agents. The obtained data show an upward trend in the detection of zoonotic pathogens in Brazilian bats, such as RABV, Bartonella sp., Histoplasma capsulatum and Leishmania spp., with emphasis on the bat species Artibeus lituratus, Carollia perspicillata, Desmodus rotundus and Molossus molossus. These findings highlight the importance of monitoring bat-associated microrganisms to early identify pathogens that may threaten bat populations, including potentially zoonotic microrganisms, emphasizing the importance of the One Health approach to prevent and mitigate the risks of the emergence of zoonotic diseases., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
9. Ex vivo wound model on porcine skin for the evaluation of the antibiofilm activity of polyhexamethylene biguanide and ciprofloxacin.
- Author
-
Guedes GMM, Pinheiro RM, Freitas AS, Pereira VC, Gomes FIF, Cordeiro RA, Sidrim JJC, Rocha MFG, and Castelo-Branco DSCM
- Subjects
- Animals, Swine, Biguanides pharmacology, Biofilms, Pseudomonas aeruginosa, Anti-Bacterial Agents pharmacology, Microbial Sensitivity Tests, Ciprofloxacin pharmacology, Staphylococcus aureus
- Abstract
This study aimed to standardize the use of an ex vivo wound model for the evaluation of compounds with antibiofilm activity. The in vitro susceptibility of Staphylococcus aureus ATCC 29213 and Pseudomonas aeruginosa ATCC 27853 to ciprofloxacin and polyhexamethylene biguanide (PHMB) was evaluated in planktonic and biofilm growth. The effects of ciprofloxacin and PHMB on biofilms grown on porcine skin explants were evaluated by colony-forming unit (CFU) counting and confocal microscopy. Minimum inhibitory concentrations (MICs) against S. aureus and P. aeruginosa were, respectively, 0.5 and 0.25 µg mL-1 for ciprofloxacin, and 0.78 and 6.25 µg mL-1 for PHMB. Minimum biofilm eradication concentrations (MBECs) against S. aureus and P. aeruginosa were, respectively, 2 and 8 µg mL-1 for ciprofloxacin, and 12.5 and >25 µg mL-1 for PHMB. Ciprofloxacin reduced (P < 0.05) log CFU counts of the biofilms grown ex vivo by 3 and 0.96 for S. aureus and P. aeruginosa, respectively, at MBEC, and by 0.58 and 8.12 against S. aureus and P. aeruginosa, respectively, at 2xMBEC. PHMB (100 µg/mL) reduced (P < 0.05) log CFU counts by 0.52 for S. aureus and 0.68 log for P. aeruginosa, leading to an overall decrease (P < 0.05) in biofilm biomass. The proposed methodology to evaluate the susceptibility of biofilms grown ex vivo led to reproducible and reliable results., (© The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International.)
- Published
- 2023
- Full Text
- View/download PDF
10. Promethazine inhibits efflux, enhances antifungal susceptibility and disrupts biofilm structure and functioning in Trichosporon .
- Author
-
Aguiar ALR, Silva BND, Fiallos NM, Pereira LMG, Silva ML, Souza PFSM, Portela FVM, Sidrim JJC, Rocha MFG, Castelo-Branco DSCM, and Cordeiro RA
- Subjects
- Humans, Promethazine pharmacology, Promethazine metabolism, Biofilms, Plankton, Microbial Sensitivity Tests, Antifungal Agents pharmacology, Antifungal Agents metabolism, Trichosporon
- Abstract
Trichosporon spp. are emerging opportunistic fungi associated with invasive infections, especially in patients with haematological malignancies. The present study investigated the in vitro inhibition of efflux pumps by promethazine (PMZ) as a strategy to control T. asahii and T. inkin . Planktonic cells were evaluated for antifungal susceptibility to PMZ, as well as inhibition of efflux. The effect of PMZ was also studied in Trichosporon biofilms. PMZ inhibited T. asahii and T. inkin planktonic cells at concentrations ranging from 32 to 256 μg
-1 . Subinhibitory concentrations of PMZ inhibited efflux activity in Trichosporon . Biofilms were completely eradicated by PMZ. PMZ potentiated the action of antifungals, affected the morphology, changed the amount of carbohydrates and proteins and reduced the amount of persister cells inside biofilms. The results showed indirect evidences of the occurrence of efflux pumps in Trichosporon and opens a perspective for the use of this target in the control of trichosporonosis.- Published
- 2023
- Full Text
- View/download PDF
11. Effect of promethazine on biofilms of gram-positive cocci associated with infectious endocarditis.
- Author
-
Guedes GMM, Melgarejo CMA, Freitas AS, Amando BR, Costa CL, Ocadaque CJ, Gomes FIF, Bandeira SP, de Aguiar Cordeiro R, Gadelha Rocha MF, Sidrim JJC, and Castelo-Branco DSCM
- Subjects
- Humans, Vancomycin pharmacology, Anti-Bacterial Agents pharmacology, Promethazine pharmacology, Ceftriaxone pharmacology, Biofilms, Oxacillin pharmacology, Staphylococcus, Microbial Sensitivity Tests, Gram-Positive Cocci, Endocarditis
- Abstract
This study evaluated the antimicrobial activity of promethazine against Staphylococcus aureus , Staphylococcus epidermidis and Streptococcus mutans and its effect on the antimicrobial susceptibility of biofilms grown in vitro and ex vivo on porcine heart valves. Promethazine was evaluated alone and in combination with vancomycin and oxacillin against Staphylococcus spp. and vancomycin and ceftriaxone against S. mutans in planktonic form and biofilms grown in vitro and ex vivo . Promethazine minimum inhibitory concentration range was 24.4-95.31 μg/mL and minimum biofilm eradication concentration range was 781.25-3.125 μg/mL. Promethazine interacted synergistically with vancomycin, oxacillin and ceftriaxone against biofilms in vitro . Promethazine alone reduced ( p < 0.05) the CFU-counts of biofilms grown on heart valves for Staphylococcus spp., but not for S. mutans , and increased ( p < 0.05) the activity of vancomycin, oxacillin and ceftriaxone against biofilms of Gram-positive cocci grown ex vivo . These findings bring perspectives for repurposing promethazine as adjuvant in the treatment of infective endocarditis.
- Published
- 2023
- Full Text
- View/download PDF
12. In vitro effect of the iron chelator deferiprone on the antimicrobial susceptibility and biofilms of Burkholderia pseudomallei .
- Author
-
Guedes GMM, Ribeiro KVC, Araújo ES, Pereira VC, Soares ACCF, Freitas AS, Cordeiro RA, Sidrim JJC, Rocha MFG, and Castelo-Branco DSCM
- Subjects
- Meropenem pharmacology, Deferiprone pharmacology, Iron pharmacology, Iron metabolism, Biofilms, Anti-Bacterial Agents pharmacology, Amoxicillin-Potassium Clavulanate Combination pharmacology, Microbial Sensitivity Tests, Iron Chelating Agents pharmacology, Burkholderia pseudomallei
- Abstract
This study evaluated the effect of the iron chelator deferiprone (DFP) on antimicrobial susceptibility and biofilm formation and maintenance by Burkholderia pseudomallei . Planktonic susceptibility to DFP alone and in combination with antibiotics was evaluated by broth microdilution and biofilm metabolic activity was determined with resazurin. DFP minimum inhibitory concentration (MIC) range was 4-64 µg/mL and in combination reduced the MIC for amoxicillin/clavulanate and meropenem. DFP reduced the biomass of biofilms by 21 and 12% at MIC and MIC/2, respectively. As for mature biofilms, DFP reduced the biomass by 47%, 59%, 52% and 30% at 512, 256, 128 and 64 µg/mL, respectively, but did not affect B. pseudomallei biofilm viability nor increased biofilm susceptibility to amoxicillin/clavulanate, meropenem and doxycycline. DFP inhibits planktonic growth and potentiates the effect of β-lactams against B. pseudomallei in the planktonic state and reduces biofilm formation and the biomass of B. pseudomallei biofilms.
- Published
- 2023
- Full Text
- View/download PDF
13. Exploring the Bacteriome and Resistome of Humans and Food-Producing Animals in Brazil.
- Author
-
de Carvalho FM, Valiatti TB, Santos FF, Silveira ACO, Guimarães APC, Gerber AL, Souza CO, Cassu Corsi D, Brasiliense DM, Castelo-Branco DSCM, Anzai EK, Bessa-Neto FO, Guedes GMM, de Souza GHA, Lemos LN, Ferraz LFC, Bahia MNM, Vaz MSM, da Silva RGB, Veiga R, Simionatto S, Monteiro WAP, Lima WAO, Kiffer CRV, Campos Pignatari AC, Cayô R, de Vasconcelos ATR, and Gales AC
- Subjects
- Humans, Swine, Cattle, Animals, Brazil, Metagenomics methods, Bacteria, Anti-Bacterial Agents pharmacology, Poultry, Genes, Bacterial, Drug Resistance, Bacterial genetics, Anti-Infective Agents
- Abstract
The epidemiology of antimicrobial resistance (AMR) is complex, with multiple interfaces (human-animal-environment). In this context, One Health surveillance is essential for understanding the distribution of microorganisms and antimicrobial resistance genes (ARGs). This report describes a multicentric study undertaken to evaluate the bacterial communities and resistomes of food-producing animals (cattle, poultry, and swine) and healthy humans sampled simultaneously from five Brazilian regions. Metagenomic analysis showed that a total of 21,029 unique species were identified in 107 rectal swabs collected from distinct hosts, the highest numbers of which belonged to the domain Bacteria , mainly Ruminiclostridium spp. and Bacteroides spp., and the order Enterobacterales . We detected 405 ARGs for 12 distinct antimicrobial classes. Genes encoding antibiotic-modifying enzymes were the most frequent, followed by genes related to target alteration and efflux systems. Interestingly, carbapenemase-encoding genes such as bla
AIM-1 , blaCAM-1 , blaGIM-2 , and blaHMB-1 were identified in distinct hosts. Our results revealed that, in general, the bacterial communities from humans were present in isolated clusters, except for the Northeastern region, where an overlap of the bacterial species from humans and food-producing animals was observed. Additionally, a large resistome was observed among all analyzed hosts, with emphasis on the presence of carbapenemase-encoding genes not previously reported in Latin America. IMPORTANCE Humans and food production animals have been reported to be important reservoirs of antimicrobial resistance (AMR) genes (ARGs). The frequency of these multidrug-resistant (MDR) bacteria tends to be higher in low- and middle-income countries (LMICs), due mainly to a lack of public health policies. Although studies on AMR in humans or animals have been carried out in Brazil, this is the first multicenter study that simultaneously collected rectal swabs from humans and food-producing animals for metagenomics. Our results indicate high microbial diversity among all analyzed hosts, and several ARGs for different antimicrobial classes were also found. As far as we know, we have detected for the first time ARGs encoding carbapenemases, such as blaAIM-1 , blaCAM-1 , blaGIM-2 , and blaHMB-1 , in Latin America. Thus, our results support the importance of metagenomics as a tool to track the colonization of food-producing animals and humans by antimicrobial-resistant bacteria. In addition, a network surveillance system called GUARANI, created for this study, is ready to be expanded and to collect additional data.- Published
- 2022
- Full Text
- View/download PDF
14. Antimicrobial susceptibility and production of virulence factors by bacteria recovered from bitches with pyometra.
- Author
-
Rocha MFG, Paiva DDQ, Amando BR, Melgarejo CMA, Freitas AS, Gomes FIF, Ocadaque CJ, Costa CL, Guedes GMM, Lima-Neto RG, Cordeiro RA, Sidrim JJC, and Castelo-Branco DSCM
- Subjects
- Animals, Dogs, Escherichia coli, Female, Hemolysin Proteins, Peptide Hydrolases, Siderophores, Virulence Factors, Anti-Infective Agents, Dog Diseases microbiology, Pyometra veterinary
- Abstract
Pyometra is one of the most common diseases in adult female dogs, characterized by a suppurative bacterial infection of the uterus with accumulation of inflammatory exudate and a variety of local and systemic clinical manifestations. This study aimed to identify the bacteria within the uterine content and vaginal canal of bitches with pyometra and evaluate their antimicrobial susceptibility and production of virulence factors. Uterine and vaginal content were collected with sterile swabs from 30 bitches diagnosed with pyometra. Bacteria were identified and assessed for their antimicrobial susceptibility and production of virulence factors, including biofilms, siderophores, proteases and hemolysins, both in planktonic and biofilm forms. A total of 82 bacterial isolates (35 uterus, 47 vagina), belonging to 21 species, were identified, with Escherichia coli as the most prevalent species (32/82, 39%). As for susceptibility, 39/79 (49.4%) isolates were resistant to one or more drugs, with resistance proportion among Gram-positive bacteria (87.5%) higher (p < .05) than that observed for Gram-negative bacteria (32.7%). Four coagulase-negative Staphylococcus species were resistant to methicillin. Regarding virulence, the isolates had low production of biofilms, siderophores, proteases and hemolysins, suggesting that the occurrence of pyometra might be more associated with host-related factors than bacterial virulence., (© 2022 Wiley-VCH GmbH.)
- Published
- 2022
- Full Text
- View/download PDF
15. Heterologous extracellular DNA facilitates the development of Trichosporon asahii and T. inkin biofilms and enhances their tolerance to antifungals.
- Author
-
Pereira LMG, Andrade ARC, Portela FVM, Aguiar ALR, Silva BND, Moura SGB, Pergentino MLM, Rocha MFG, Sidrim JJDC, Castelo Branco DSCM, and Cordeiro RA
- Subjects
- Humans, Biofilms, Microbial Sensitivity Tests, DNA, Deoxyribonucleases, Antifungal Agents pharmacology, Trichosporon genetics
- Abstract
Trichosporon asahii and T. inkin are emergent agents of deep-seated and disseminated infections in immunocompromised patients. The present study aimed to investigate the role of extracellular DNA (eDNA) and the enzyme deoxyribonuclease (DNase) on the structure of T. asahii and T. inkin biofilms, as well as to examine their effect on the susceptibility to antifungals. Biofilms reached maturity at 48 h; eDNA concentration in the supernatant increased over time (6 < 24 h < 48h). Exogenous eDNA increased biomass of Trichosporon biofilms at all stages of development, enhanced their tolerance to antifungals and improved their structural complexity. DNase reduced biomass, biovolume and thickness of Trichosporon biofilms, thereby rendering them more susceptibility to voriconazole. The results suggest the relevance of eDNA in the structure and antifungal susceptibility of Trichosporon biofilms and highlight the potential of DNase as adjuvant in biofilm control.
- Published
- 2022
- Full Text
- View/download PDF
16. The herbicide paraquat alters growth and melanin production on the Cryptococcus neoformans/Cryptococcus gattii species complex.
- Author
-
Castelo-Branco DSCM, da Rocha MG, de Oliveira JS, Araújo GDS, Martins DV, Garcia LGS, Cordeiro RA, Sidrim JJC, Pereira-Neto WA, de Melo Guedes GM, Brilhante RSN, and Rocha MFG
- Subjects
- Antifungal Agents metabolism, Antifungal Agents pharmacology, Levodopa metabolism, Levodopa pharmacology, Melanins metabolism, Melanins pharmacology, Microbial Sensitivity Tests, Paraquat metabolism, Paraquat pharmacology, Cryptococcus gattii metabolism, Cryptococcus neoformans metabolism, Herbicides metabolism, Herbicides pharmacology
- Abstract
Paraquat (1,10-dimethyl-4,4-bipyridinium dichloride; PQ) is a free-radical producing herbicide that affects cell membranes and can upset the environmental balance of microorganisms present in soil, such as Cryptococcus spp. This study aimed to evaluate the in vitro activity of PQ against Cryptococcus spp. in planktonic and biofilm forms, as well as the protective effect of antioxidant agents against the antifungal effect of PQ and the kinetics of melanin production in response to PQ. Susceptibility to PQ was evaluated by microdilution. Cryptococcus sp. strains exposed to PQ were grown in media with ascorbic acid (AA) and glutathione (GSH). Melanin production was assessed in the presence of l-3,4-dihydroxyphenylalanine (l-DOPA) + PQ. The minimum inhibitory concentration of PQ against Cryptococcus spp. ranged from 8 to 256 µg/mL. Furthermore, PQ reduced biofilm formation. AA and GSH restored the fungal growth of Cryptococcus spp. exposed to PQ. In addition, l-DOPA + PQ delayed melanin production by 24 and 48 h for C . deuterogattii and C. neoformans sensu lato, respectively, suggesting that PQ induces a fitness trade-off in melanin production. Taken together, our data suggest that the antifungal effect of PQ against Cryptococcus spp. possibly exerts selective pressures interfering with biofilm formation and melanin production by these yeasts.
- Published
- 2022
- Full Text
- View/download PDF
17. The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.
- Author
-
Souza PFN, Mesquita FP, Amaral JL, Landim PGC, Lima KRP, Costa MB, Farias IR, Belém MO, Pinto YO, Moreira HHT, Magalhaes ICL, Castelo-Branco DSCM, Montenegro RC, and de Andrade CR
- Subjects
- Glycoproteins genetics, Humans, Mutation, Spike Glycoprotein, Coronavirus metabolism, COVID-19 epidemiology, SARS-CoV-2 genetics
- Abstract
Late in 2019, SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) emerged, causing an unknown type of pneumonia today called coronaviruses disease 2019 (COVID-19). COVID-19 is still an ongoing global outbreak that has claimed and threatened many lives worldwide. Along with the fastest vaccine developed in history to fight SARS-CoV-2 came a critical problem, SARS-CoV-2. These new variants are a result of the accumulation of mutations in the sequence and structure of spike (S) glycoprotein, which is by far the most critical protein for SARS-CoV-2 to recognize cells and escape the immune system, in addition to playing a role in SARS-CoV-2 infection, pathogenicity, transmission, and evolution. In this review, we discuss mutation of S protein and how these mutations have led to new variants that are usually more transmissible and can thus mitigate the immunity produced by vaccination. Here, analysis of S protein sequences and structures from variants point out the mutations among them, how they emerge, and the behavior of S protein from each variant. This review brings details in an understandable way about how the variants of SARS-CoV-2 are a result of mutations in S protein, making them more transmissible and even more aggressive than their relatives., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
18. Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2.
- Author
-
Souza PFN, vanTilburg MF, Mesquita FP, Amaral JL, Lima LB, Montenegro RC, Lopes FES, Martins RX, Vieira L, Farias DF, Monteiro-Moreira ACO, Freitas CDT, Bezerra AS, Guedes MIF, Castelo-Branco DSCM, and Oliveira JTA
- Abstract
The outbreak caused by SARS-CoV-2 has taken many lives worldwide. Although vaccination has started, the development of drugs to either alleviate or abolish symptoms of COVID-19 is still necessary. Here, four synthetic peptides were assayed regarding their ability to protect Vero E6 cells from SARS-CoV-2 infection and their toxicity to human cells and zebrafish embryos. All peptides had some ability to protect cells from infection by SARS-CoV-2 with the D614G mutation. Molecular docking predicted the ability of all peptides to interact with and induce conformational alterations in the spike protein containing the D614G mutation. PepKAA was the most effective peptide, by having the highest docking score regarding the spike protein and reducing the SARS-CoV-2 plaque number by 50% (EC
50 ) at a concentration of 0.15 mg mL-1 . Additionally, all peptides had no toxicity to three lines of human cells as well as to zebrafish larvae and embryos. Thus, these peptides have potential activity against SARS-CoV-2, making them promising to develop new drugs to inhibit cell infection by SARS-CoV-2., Competing Interests: The authors declare no competing financial interest., (© 2022 The Authors. Published by American Chemical Society.)- Published
- 2022
- Full Text
- View/download PDF
19. Anti-Staphylococcal Activity of Cinnamomum zeylanicum Essential Oil against Planktonic and Biofilm Cells Isolated from Canine Otological Infections.
- Author
-
Albuquerque VQ, Soares MJC, Matos MNC, Cavalcante RMB, Guerrero JAP, Soares Rodrigues TH, Gomes GA, de Medeiros Guedes RF, Castelo-Branco DSCM, Goes da Silva IN, and Carneiro VA
- Abstract
The aim of this study was to evaluate the phytochemical profile of Cinnamomum zeylanicum essential oil (CZEO) and their antimicrobial and antibiofilm activity against Staphylococcus strains isolated from canine otitis. First, the CZEO chemical composition was determined by gas chromatography-mass spectrometry (CG-MS). External otitis samples collected from dogs were submitted to staphylococcal isolation, followed by MALDI-TOF mass spectrometry identification. The antimicrobial action was tested against the isolates using the disk-diffusion and microdilution methods. The antibiofilm activity was evaluated by CZEO-based concentrations, subMIC for biofilm formation and supraMIC against preformed biofilm, quantified by crystal violet (CV) staining and CFU counting. The chemical analysis revealed that (E)-cinnamaldehyde, eugenol and (E)-cinnamyl acetate were the main compounds in the CZEO, representing 77.42, 8.17 and 4.50%, respectively. Two strains of three different species, S. saprophyticus , S. schleiferi and S. pseudintermedius , were identified. The disk-diffusion test showed an inhibitory zone diameter, ranging from 34.0 to 49.5 mm, while the MIC and MBC values were around 500 and 1000 µg/mL. SubMIC demonstrated an inhibition on biofilm formation against 4 out the 6 strains tested. On mature biofilm, the CZEO-based supraMIC groups had slightly change on biomass, however, the biofilm cell viability decreased the CFU in 3 magnitude orders.
- Published
- 2021
- Full Text
- View/download PDF
20. Azole-Resilient Biofilms and Non-wild Type C. albicans Among Candida Species Isolated from Agricultural Soils Cultivated with Azole Fungicides: an Environmental Issue?
- Author
-
Sidrim JJC, de Maria GL, Paiva MAN, Araújo GDS, da Graça-Filho RV, de Oliveira JS, Sales JA, Pereira-Neto WA, Guedes GMM, Castelo-Branco DSCM, Cordeiro RA, Brilhante RSN, and Rocha MFG
- Subjects
- Antifungal Agents pharmacology, Azoles pharmacology, Biofilms, Candida albicans, Microbial Sensitivity Tests, Soil, Candida genetics, Fungicides, Industrial pharmacology
- Abstract
This study aimed to identify Candida spp. from agricultural soils cultivated with azole fungicides and investigate their susceptibility to clinical (fluconazole, itraconazole, voriconazole, and amphotericin B) and agricultural (tetraconazole and tebuconazole) antifungals in planktonic form. Additionally, Candida biofilm-forming ability and biofilm susceptibility to agricultural antifungals and voriconazole were analyzed. Species identification was performed by phenotypic and molecular assays. The susceptibility of planktonic cells was evaluated by the broth microdilution method. The biofilm metabolic activity was evaluated by the XTT reduction assay. The recovered Candida spp. were identified as C. parapsilosis sensu stricto (n = 14), C. albicans (n = 5), C. tropicalis (n = 2), C. fermentati (n = 1), and C. metapsilosis (n = 2). Minimum inhibitory concentration ranges for clinical and agricultural antifungals were ≤ 0.03-4 μg/mL and 1-128 μg/mL, respectively. Two and one C. albicans strains were considered non-wild type for voriconazole and fluconazole, respectively. All strains were biofilm producers. The minimum biofilm inhibitory concentration ranges for tetraconazole and tebuconazole were 128-> 1024 μg/mL, while for voriconazole was 512-> 1024 μg/mL. In summary, this study shows that non-wild type and azole-resilient biofilm-producing Candida species colonize agricultural soils cultivated with azole fungicides., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
21. Ex situ model of biofilm-associated wounds: providing a host-like environment for the study of Staphylococcus aureus and Pseudomonas aeruginosa biofilms.
- Author
-
Guedes GMM, Santos-Filho ASP, Regis WFM, Ocadaque CJ, Amando BR, Sidrim JJC, Brilhante RSN, Cordeiro RA, Bandeira SP, Rocha MFG, and Castelo-Branco DSCM
- Subjects
- Animals, In Vitro Techniques, Pseudomonas Infections, Staphylococcal Infections, Swine, Wounds and Injuries microbiology, Biofilms, Pseudomonas aeruginosa growth & development, Pseudomonas aeruginosa pathogenicity, Skin microbiology, Staphylococcus aureus growth & development, Staphylococcus aureus pathogenicity
- Abstract
Aim: This study aimed to assess an ex situ model of biofilm-associated wounds on porcine skin for the study of Staphylococcus aureus and Pseudomonas aeruginosa biofilms in a host-like environment, after 48 to 120 h of incubation., Material and Results: Ex situ and in vitro biofilms were comparatively analysed. Overall, CFU-counts and matrix quantification yielded significantly (P < 0·05) higher results for ex situ than in vitro biofilms. Confocal microscopy revealed greater (P < 0·05) biomass and thickness at 48-72 h and greater (P < 0·05) robustness at 72 h of growth. S. aureus ex situ biofilms produced less (P < 0·05) siderophore and proteases than in vitro biofilms, while P. aeruginosa ex situ biofilms produced more (P < 0·05) siderophores and less proteases than in vitro biofilms., Conclusions: Biofilms grown ex situ present a greater amount of bacterial cells and polymeric matrix than their in vitro counterparts, reaching maturity at 72 h of growth. Moreover the production of virulence factors differs between ex situ and in vitro biofilms., Significance and Impact of the Study: These findings emphasize the importance of using ex situ biofilm models, once they mimic in vivo conditions. The use of these models brings perspectives for the pursuit of therapeutic alternatives, as tests may be performed in a host-like environment., (© 2021 The Society for Applied Microbiology.)
- Published
- 2021
- Full Text
- View/download PDF
22. Vancomycin enhances growth and virulence of Trichosporon spp. planktonic cells and biofilms.
- Author
-
de Aguiar Cordeiro R, da Silva BN, de Aguiar ALR, Pereira LMG, Portela FVM, da Rocha MG, Pergentino MLM, de Santos Sales G, de Sousa JK, de Camargo ZP, Brilhante RSN, Rocha MFG, Castelo-Branco DSCM, and Sidrim JJC
- Subjects
- Biofilms drug effects, Biofilms growth & development, Microscopy, Electron, Scanning, Plankton drug effects, Plankton growth & development, Plankton pathogenicity, Trichosporon growth & development, Trichosporon pathogenicity, Trichosporon physiology, Virulence drug effects, Anti-Bacterial Agents pharmacology, Trichosporon drug effects, Vancomycin pharmacology
- Abstract
Invasive fungal infections (IFIs) are important worldwide health problem, affecting the growing population of immunocompromised patients. Although the majority of IFIs are caused by Candida spp., other fungal species have been increasingly recognized as relevant opportunistic pathogens. Trichosporon spp. are members of skin and gut human microbiota. Since 1980's, invasive trichosporonosis has been considered a significant cause of fungemia in patients with hematological malignancies. As prolonged antibiotic therapy is an important risk factor for IFIs, the present study investigated if vancomycin enhances growth and virulence of Trichosporon. Vancomycin was tested against T. inkin (n = 6) and T. asahii (n = 6) clinical strains. Planktonic cells were evaluated for their metabolic activity and virulence against Caenorhabditis elegans. Biofilms were evaluated for metabolic activity, biomass production, amphotericin B tolerance, induction of persister cells, and ultrastructure. Vancomycin stimulated planktonic growth of Trichosporon spp., increased tolerance to AMB, and potentiates virulence against C. elegans. Vancomycin stimulated growth (metabolic activity and biomass) of Trichosporon spp. biofilms during all stages of development. The antibiotic increased the number of persister cells inside Trichosporon biofilms. These cells showed higher tolerance to AMB than persister cells from VAN-free biofilms. Microscopic analysis showed that VAN increased production of extracellular matrix and cells in T. inkin and T. asahii biofilms. These results suggest that antibiotic exposure may have a direct impact on the pathophysiology of opportunistic trichosporonosis in patients at risk., Lay Abstract: This study showed that the vancomycin stimulated Trichosporon growth, induced morphological and physiological changes on their biofilms, and also enhanced their in vivo virulence. Although speculative, the stimulatory effect of vancomycin on fungal cells should be considered in a clinical scenario., (© The Author(s) 2021. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2021
- Full Text
- View/download PDF
23. Inhibitory effect of Brazilian red propolis on planktonic and biofilm forms of Clostridioides difficile.
- Author
-
Costa CL, Azevedo CP, Quesada-Gómez C, Brito GAC, Regueira-Neto MDS, Guedes GMM, Rocha MFG, Sidrim JJC, Cordeiro RA, Carvalho CBM, and Castelo-Branco DSCM
- Subjects
- Brazil, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacokinetics, Biofilms drug effects, Clostridioides difficile drug effects, Plankton drug effects, Propolis chemistry, Propolis pharmacokinetics, Vancomycin pharmacokinetics
- Abstract
Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacillus which is the leading cause of health-care-associated infective diarrhea. The rising incidence of antibiotic resistance in pathogens such as C. difficile makes researches on alternative antibacterial products very important, especially those exploring natural products like propolis. Brazilian Red Propolis, found in the Northeast region of Brazil, is composed by products from regional plants that have the antimicrobial properties. This study aimed to evaluate the in vitro activity of Brazilian Red Propolis (BRP) against C. difficile strains in planktonic and biofilm forms. The susceptibility of four strains of C. difficile to BRP was analyzed by broth microdilution method and vancomycin was included as control drug. BRP-exposed C. difficile cells were evaluated by scanning electron microscopy (SEM). Then, the effects of BRP on growing and mature C. difficile biofilms were also evaluated. BRP minimum inhibitory concentration was 625 μg/mL against all tested strains, while vancomycin MIC range was 0.5-2 μg/mL. SEM showed the loss of homogeneity in bacterial cell wall and cell fragmentation, after BRP-exposure. BRP, at MIC, reduced (P < 0.05) the biomass, matrix proteins and matrix carbohydrates of growing biofilms, and, at 8xMIC, reduced (P < 0.05) the biomass and matrix proteins of mature biofilms. The present study demonstrated that BRP inhibits planktonic growth, damages cell wall, decreases biofilm growth and harms mature biofilms of C. difficile., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
24. Trichosporon asahii and Trichosporon inkin Biofilms Produce Antifungal-Tolerant Persister Cells.
- Author
-
Cordeiro RA, Aguiar ALR, da Silva BN, Pereira LMG, Portela FVM, de Camargo ZP, de Lima-Neto RG, Castelo-Branco DSCM, Rocha MFG, and Sidrim JJC
- Subjects
- Antifungal Agents, Basidiomycota, Biofilms, Humans, Microbial Sensitivity Tests, Trichosporon
- Abstract
Persister cells are metabolically inactive dormant cells that lie within microbial biofilms. They are phenotypic variants highly tolerant to antimicrobials and, therefore, associated with recalcitrant infections. In the present study, we investigated if Trichosporon asahii and T. inkin are able to produce persister cells. Trichosporon spp. are ubiquitous fungi, commonly found as commensals of the human skin and gut microbiota, and have been increasingly reported as agents of fungemia in immunocompromised patients. Biofilms derived from clinical strains of T asahii (n=5) and T. inkin (n=7) were formed in flat-bottomed microtiter plates and incubated at 35°C for 48 h, treated with 100 μg/ml amphotericin B (AMB) and incubated at 35°C for additional 24 h. Biofilms were scraped from the wells and persister cells were assayed for susceptibility to AMB. Additionally, we investigated if these persister cells were able to generate new biofilms and studied their ultrastructure and AMB susceptibility. Persister cells were detected in both T asahii and T. inkin biofilms and showed tolerance to high doses of AMB (up to 256 times higher than the minimum inhibitory concentration). Persister cells were able to generate biofilms, however they presented reduced biomass and metabolic activity, and reduced tolerance to AMB, in comparison to biofilm growth control. The present study describes the occurrence of persister cells in Trichosporon spp. and suggests their role in the reduced AMB susceptibility of T . asahii and T. inkin biofilms., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Cordeiro, Aguiar, Silva, Pereira, Portela, Camargo, Lima-Neto, Castelo-Branco, Rocha and Sidrim.)
- Published
- 2021
- Full Text
- View/download PDF
25. Genomic Diversity of Burkholderia pseudomallei in Ceara, Brazil.
- Author
-
Gee JE, Gulvik CA, Castelo-Branco DSCM, Sidrim JJC, Rocha MFG, Cordeiro RA, Brilhante RSN, Bandeira TJPG, Patrício I, Alencar LP, da Costa Ribeiro AK, Sheth M, Deka MA, Hoffmaster AR, and Rolim D
- Subjects
- Bacterial Typing Techniques, Brazil epidemiology, DNA, Bacterial genetics, Disease Outbreaks statistics & numerical data, Genomics methods, Genotype, Humans, Male, Melioidosis epidemiology, Melioidosis microbiology, Phylogeny, Sequence Analysis, DNA, Burkholderia pseudomallei classification, Burkholderia pseudomallei genetics, Genetic Variation, Genome, Bacterial
- Abstract
Burkholderia pseudomallei is a Gram-negative bacterium that causes the sapronotic disease melioidosis. An outbreak in 2003 in the state of Ceara, Brazil, resulted in subsequent surveillance and environmental sampling which led to the recognition of B. pseudomallei as an endemic pathogen in that area. From 2003 to 2015, 24 clinical and 12 environmental isolates were collected across Ceara along with one from the state of Alagoas. Using next-generation sequencing, multilocus sequence typing, and single nucleotide polymorphism analysis, we characterized the genomic diversity of this collection to better understand the population structure of B. pseudomallei associated with Ceara. We found that the isolates in this collection form a distinct subclade compared to other examples from the Western Hemisphere. Substantial genetic diversity among the clinical and environmental isolates was observed, with 14 sequence types (STs) identified among the 37 isolates. Of the 31,594 core single-nucleotide polymorphisms (SNPs) identified, a high proportion (59%) were due to recombination. Because recombination events do not follow a molecular clock, the observation of high occurrence underscores the importance of identifying and removing recombination SNPs prior to evolutionary reconstructions and inferences in public health responses to B. pseudomallei outbreaks. Our results suggest long-term B. pseudomallei prevalence in this recently recognized region of melioidosis endemicity. IMPORTANCE B. pseudomallei causes significant morbidity and mortality, but its geographic prevalence and genetic diversity are not well characterized, especially in the Western Hemisphere. A better understanding of the genetic relationships among clinical and environmental isolates will improve knowledge of the population structure of this bacterium as well as the ability to conduct epidemiological investigations of cases of melioidosis.
- Published
- 2021
- Full Text
- View/download PDF
26. Atypical chlamydoconidium-producing Trichophyton tonsurans strains from Ceará State, Northeast Brazil: investigation of taxonomy by phylogenetic analysis and biofilm susceptibility.
- Author
-
Brilhante RSN, Paixão GC, Pereira VS, Oliveira JS, Maciel JM, Pereira-Neto WA, Lima-Neto RG, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, and Rocha MFG
- Subjects
- Arthrodermataceae cytology, Arthrodermataceae drug effects, Arthrodermataceae physiology, Biofilms growth & development, Brazil, DNA, Fungal genetics, DNA, Ribosomal genetics, Farnesol pharmacology, Fungal Proteins genetics, Humans, Microbial Sensitivity Tests, Sequence Analysis, DNA, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Spores, Fungal classification, Spores, Fungal cytology, Terbinafine pharmacology, Tubulin genetics, Antifungal Agents pharmacology, Arthrodermataceae classification, Biofilms drug effects, Phylogeny
- Abstract
Chlamydoconidium-producing Trichophyton tonsurans strains isolated in Northeastern Brazil have morphological features different from the classic description of this dermatophyte species. This study investigated the phylogenetic relationship of chlamydoconidium-producing T. tonsurans strains isolated in Northeastern Brazil. Also, the effect of terbinafine and farnesol on mature biofilms of T. tonsurans strains was evaluated. The mass spectra of T. tonsurans strains were investigated by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). The ITS and LSU loci regions of rDNA and the partial β-tubulin gene were sequenced and the phylogenetic tree was analysed. The effects of terbinafine and farnesol on mature T. tonsurans biofilms were evaluated through the analysis of metabolic activity, quantification of biomass and observation by scanning electron microscopy. MALDI-TOF MS spectra of the chlamydoconidium-producing T. tonsurans strains differed from the spectrum of the control strain (ATCC 28942), presenting an intense ion peak at m/z 4155 Da. Phylogenetic tree analysis showed that the chlamydoconidium-producing strains isolated in Northeastern Brazil are allocated to a single cluster, differing from strains isolated from other countries. As for mature T. tonsurans biofilms, farnesol reduced biomass and metabolic activity by 64.4 and 65.9 %, respectively, while terbinafine reduced the biomass by 66.5 % and the metabolic activity by 69 %. Atypical morphological characteristics presented by chlamydoconidium-producing T. tonsurans strains result from phenotypic plasticity, possibly for adaptation to environmental stressors. Also, farnesol had inhibitory activity against T. tonsurans biofilms, demonstrating this substance can be explored for development of promising anti-biofilm drugs against dermatophytes.
- Published
- 2021
- Full Text
- View/download PDF
27. Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans/Cryptococcus gattii complex species.
- Author
-
Brilhante RSN, Gotay WJP, Pereira VS, de Oliveira JS, Pereira-Neto WA, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, and Rocha MFG
- Subjects
- Antifungal Agents therapeutic use, Humans, Microbial Sensitivity Tests, Biofilms drug effects, Chlorpromazine therapeutic use, Cryptococcosis drug therapy, Cryptococcus gattii drug effects, Cryptococcus neoformans drug effects, Drug Resistance, Fungal drug effects, Plankton drug effects, Promethazine therapeutic use
- Abstract
Cryptococcus neoformans/Cryptococcus gattii are fungal pathogens that affect the central nervous system, mainly in immunocompromised individuals. Due to the limited pharmacological arsenal available for the treatment of cryptococcosis associated with cases of antifungal resistance of Cryptococcus spp. reported in some studies, the search for new compounds with antifungal potential becomes relevant. Thus, the objective of this study was to evaluate the inhibitory effect of phenothiazines (promethazine and chlorpromazine) on C. neoformans/C. gattii planktonic cells and biofilms. In vitro planktonic susceptibility testing was performed using the broth microdilution assay. The effect of phenothiazines was evaluated against biofilm formation and mature Cryptococcus biofilms. Biofilm morphology and ultrastructure were also evaluated by scanning electron microscopy. Promethazine and chlorpromazine showed antifungal activity against planktonic cells, with minimum inhibitory concentrations of 8-32 μg/ml and 4-16 μg/ml, respectively. As for biofilm formation, phenothiazines reduced biomass by 60% and metabolic activity by 90% at 64 μg/ml; while in mature biofilms, reductions of 85% and 90% in biomass and metabolic activity, respectively, were observed at 1024 μg/ml. Promethazine and chlorpromazine were also able to disrupt and fragment biofilms. In conclusion, promethazine and chlorpromazine have antifungal activity against planktonic cells and biofilms of Cryptococcus spp. These data show the potential of promethazine and chlorpromazine as antibiofilm drugs., (© The Author(s) 2020. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2020
- Full Text
- View/download PDF
28. Mini-review: from in vitro to ex vivo studies: an overview of alternative methods for the study of medical biofilms.
- Author
-
Castelo-Branco DSCM, Amando BR, Ocadaque CJ, Aguiar L, Paiva DDQ, Diógenes EM, Guedes GMM, Costa CL, Santos-Filho ASP, Andrade ARC, Cordeiro RA, Rocha MFG, and Sidrim JJC
- Subjects
- Animals, Biomass, Biofilms
- Abstract
Microbial biofilms are a natural adaptation of microorganisms, typically composed of multiple microbial species, exhibiting complex community organization and cooperation. Biofilm dynamics and their complex architecture are challenging for basic analyses, including the number of viable cells, biomass accumulation, biofilm morphology, among others. The methods used to study biofilms range from in vitro techniques to complex in vivo models. However, animal welfare has become a major concern, not only in society, but also in the academic and scientific field. Thus, the pursuit for alternatives to in vivo biofilm analyses presenting characteristics that mimic in vivo conditions has become essential. In this context, the present review proposes to provide an overview of strategies to study biofilms of medical interest, with emphasis on alternatives that approximate experimental conditions to host-associated environments, such as the use of medical devices as substrata for biofilm formation, microcosm and ex vivo models.
- Published
- 2020
- Full Text
- View/download PDF
29. Azole resistance in Candida from animals calls for the One Health approach to tackle the emergence of antimicrobial resistance.
- Author
-
Castelo-Branco DSCM, Paiva MAN, Teixeira CEC, Caetano ÉP, Guedes GMM, Cordeiro RA, Brilhante RSN, Rocha MFG, and Sidrim JJC
- Subjects
- Animals, Antifungal Agents therapeutic use, Candidiasis veterinary, Female, Humans, Male, Candida albicans drug effects, Candida parapsilosis drug effects, Candida tropicalis drug effects, Candidiasis drug therapy, Drug Resistance, Fungal drug effects, Fluconazole therapeutic use, Itraconazole therapeutic use, Voriconazole therapeutic use
- Abstract
This study initially aimed at investigating the occurrence of azole resistance among Candida spp. from animals and analyzing the involvement of efflux pumps in the resistance phenomenon. Then, the dynamics of antifungal resistance was assessed, by comparing the antifungal epidemiological cutoff values (ECVs) against C. albicans and C. tropicalis from humans and animals. Fifty azole-resistant isolates (24 C. albicans, 24 C. tropicalis; 2 C. parapsilosis sensu lato) were submitted to the efflux pump inhibition assay with promethazine and significant MIC reductions were observed for fluconazole (2 to 250-fold) and itraconazole (16 to 4000-fold). Then, the antifungal ECVs against C. albicans and C. tropicalis from human and animal isolates were compared. Fluconazole, itraconazole and voriconazole ECVs against human isolates were lower than those against animal isolates. Based on the antifungal ECVs against human isolates, only 33.73%, 50.39% and 63.53% of C. albicans and 52.23%, 61.85% and 55.17% of C. tropicalis from animals were classified as wild-type for fluconazole, itraconazole and voriconazole, respectively. Therefore, efflux-mediated mechanisms are involved in azole resistance among Candida spp. from animals and this phenomenon seems to emerge in animal-associated niches, pointing to the existence of environmental drivers of resistance and highlighting the importance of the One Health approach to control it., (© The Author(s) 2020. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2020
- Full Text
- View/download PDF
30. Antifungal effect of anthraquinones against Cryptococcus neoformans: detection of synergism with amphotericin B.
- Author
-
Brilhante RSN, Araújo GDS, Fonseca XMQC, Guedes GMM, Aguiar L, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, Pereira Neto WA, and Rocha MFG
- Abstract
The emergence of tolerant Cryptococcus neoformans strains to antifungals has been described. It has directed researchers to screen for new antimicrobial compounds. In this context, several plant-derived compounds, such as anthraquinones (aloe emodin, barbaloin, and chrysophanol), have been investigated for their antimicrobial properties. This study aimed to evaluate the in vitro effect of aloe emodin, barbaloin and chrysophanol on C. neoformans in vitro growth. In addition, the interaction between these anthraquinones and amphotericin B and itraconazole was evaluated. Initially, the minimum inhibitory concentrations (MIC) of these compounds were determined against 17 strains of C. neoformans by the broth microdilution method and then pharmacological interaction assays were performed with 15 strains by the checkerboard method. Aloe emodin, barbaloin, and chrysophanol showed minimum inhibitory concentrations of 236.82-473.65 μM (64-128 μg/mL), 153-306 μM (64-128 μg/ml) and ≥1007 μM (≥256 μg/ml), respectively. Furthermore, aloe emodin (11/15), barbaloin (13/15), and chrysophanol (12/15) showed pharmacological synergism (FICI < 0.5) with amphotericin B at subinhibitory concentrations (MIC/4). The itraconazole-aloe emodin interaction was additive (1/15) (0.5 < FICI < 1.0). The itraconazole-barbaloin interaction were synergistic (2/15) and additive (5/15); whereas itraconazole-chrysophanol interactions were additive (2/15). Anthraquinones, especially aloe emodin and barbaloin, present in vitro antifungal activity against C. neoformans and potentiate the antifungal activity of amphotericin B., (© The Author(s) 2020. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2020
- Full Text
- View/download PDF
31. In vitro and ex vivo biofilms of dermatophytes: a new panorama for the study of antifungal drugs.
- Author
-
Castelo-Branco DSCM, Aguiar L, Araújo GDS, Lopes RGP, Sales JA, Pereira-Neto WA, Pinheiro AQ, Paixão GC, Cordeiro RA, Sidrim JJC, Brilhante RSN, and Rocha MFG
- Subjects
- Antifungal Agents pharmacology, Microbial Sensitivity Tests, Arthrodermataceae, Biofilms, Pharmaceutical Preparations
- Abstract
This study describes an ex vivo model that creates an environment for dermatophyte biofilm growth, with features that resemble those of in vivo conditions, designing a new panorama for the study of antifungal susceptibility. Regarding planktonic susceptibility, MIC ranges were 0.125-1 µg ml
-1 for griseofulvin and 0.000097-0.25 µg ml-1 for itraconazole and terbinafine. sMIC50 ranges were 2->512 µg ml-1 for griseofulvin and 0.25->64 µg ml-1 for itraconazole and terbinafine. CLSM images demonstrated a reduction in the amount of cells within the biofilm, but hyphae and conidia were still observed and biofilm biomass was maintained. SEM analysis demonstrated a retraction in the biofilm matrix, but fungal structures and water channels were preserved. These results show that ex vivo biofilms are more tolerant to antifungal drugs than in vitro biofilms, suggesting that environmental and nutritional conditions created by this ex vivo model favor biofilm growth and robustness, and hence drug tolerance.- Published
- 2020
- Full Text
- View/download PDF
32. Darunavir inhibits Cryptococcus neoformans / Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugs.
- Author
-
Brilhante RSN, Silva JAT, Araújo GDS, Pereira VS, Gotay WJP, Oliveira JS, Guedes GMM, Pereira-Neto WA, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, and Rocha MFG
- Subjects
- Amphotericin B pharmacology, Cells, Cultured, Fluconazole pharmacology, Microbial Sensitivity Tests methods, Plankton microbiology, Antifungal Agents pharmacology, Biofilms drug effects, Cryptococcus gattii drug effects, Cryptococcus neoformans drug effects, Darunavir pharmacology
- Abstract
Introduction. Cryptococcus species are pathogens commonly associated with cases of meningoencephalitis in individuals who are immunosuppressed due to AIDS. Aim. The aim was to evaluate the effects of the antiretroviral darunavir alone or associated with fluconazole, 5-flucytosine and amphotericin B against planktonic cells and biofilms of Cryptococcus species. Methodology. Susceptibility testing of darunavir and the common antifungals against 12 members of the Cryptococcus neoformans / Cryptococcus gattii species complex was evaluated by broth microdilution. The interaction between darunavir and antifungals against planktonic cells was tested by a checkerboard assay. The effects of darunavir against biofilm metabolic activity and biomass were evaluated by the XTT reduction assay and crystal violet staining, respectively. Results. Darunavir combined with amphotericin B showed a synergistic interaction against planktonic cells. No antagonistic interaction was observed between darunavir and the antifungals used. All Cryptococcus species strains were strong biofilm producers. Darunavir alone reduced biofilm metabolic activity and biomass when added during and after biofilm formation ( P <0.05). The combination of darunavir with antifungals caused a significant reduction in biofilm metabolic activity and biomass when compared to darunavir alone ( P <0.05). Conclusion. Darunavir presents antifungal activity against planktonic cells of Cryptococcus species and synergism with amphotericin B. In addition, darunavir led to reduced biofilm formation and showed activity against mature biofilms of Cryptococcus species. Activity of the antifungals against mature biofilms was enhanced in the presence of darunavir.
- Published
- 2020
- Full Text
- View/download PDF
33. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
- Author
-
Brilhante RSN, Rocha MGD, Oliveira JS, Pereira-Neto WA, Guedes GMM, Cordeiro RA, Sidrim JJC, Rocha MFG, and Castelo-Branco DSCM
- Subjects
- Animals, Anti-Bacterial Agents, Caffeic Acids metabolism, Caffeic Acids pharmacology, Cryptococcus gattii drug effects, Cryptococcus neoformans drug effects, Dopamine metabolism, Dopamine pharmacology, Epinephrine metabolism, Humans, Microbial Sensitivity Tests, Norepinephrine metabolism, Norepinephrine pharmacology, Amphotericin B pharmacology, Antifungal Agents pharmacology, Cryptococcus gattii metabolism, Cryptococcus neoformans metabolism, Epinephrine pharmacology, Melanins metabolism
- Abstract
Cryptococcus neoformans/Cryptococcus gattii complex species are etiological agents of cryptococcosis, a systemic mycosis that cause respiratory infection and meningoencephalitis. To establish the infection, these yeasts produce virulence factors, such as melanin, which contribute to pathogenicity and antifungal tolerance. The aim of this study was to investigate melanin production by the C. neoformans/C. gattii complex in the presence of different precursors of melanogenesis and evaluate the effect of melanization on the antifungal susceptibility of these species to fluconazole, flucytosine and amphotericin B. Epinephrine, norepinephrine, dopamine and caffeic acid were used as substrates for melanin production, and l-dopa was used as positive control. The susceptibility of melanized strains (n = 6), after exposure to epinephrine or l-dopa, was evaluated by broth microdilution assay, and non-melanized strains were used as control. The antifungal activity of amphotericin B against melanized strains was also investigated by time kill assay. All Cryptococcus spp. strains produced melanin after exposure to the tested substrates. After exposure to epinephrine, minimum inhibitory concentration (MIC) ranges were 1-8 μg/mL for fluconazole, 2-8 μg/mL for flucytosine and 0.125-1 μg/mL for amphotericin B, while, after exposure to l-dopa, MIC ranges were 2-8 μg/mL for fluconazole, 4-8 μg/mL for flucytosine, and 0.125-0.5 μg/mL for amphotericin B. Similar results were observed for non-melanized strains. The production of melanin after exposure to epinephrine was higher than that induced by l-dopa. Melanized cells of both species were more tolerant to amphotericin B than the non-melanized control, emphasizing the importance of melanin production for fungal virulence., Competing Interests: Declaration of competing interest None., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
34. The yeast, the antifungal, and the wardrobe: a journey into antifungal resistance mechanisms of Candida tropicalis .
- Author
-
Oliveira JS, Pereira VS, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, Brilhante RSN, and Rocha MFG
- Subjects
- Candida tropicalis drug effects, Candidiasis diagnosis, Candidiasis drug therapy, Humans, Antifungal Agents pharmacology, Azoles pharmacology, Candida tropicalis genetics, Candidiasis microbiology, Drug Resistance, Fungal genetics
- Abstract
Candida tropicalis is a prominent non- Candida albicans Candida species involved in cases of candidemia, mainly causing infections in patients in intensive care units and (or) those presenting neutropenia. In recent years, several studies have reported an increase in the recovery rates of azole-resistant C. tropicalis isolates. Understanding C. tropicalis resistance is of great importance, since resistant strains are implicated in persistent or recurrent and breakthrough infections. In this review, we address the main mechanisms underlying C. tropicalis resistance to the major antifungal classes used to treat candidiasis. The main genetic basis involved in C. tropicalis antifungal resistance is discussed. A better understanding of the epidemiology of resistant strains and the mechanisms involved in C. tropicalis resistance can help improve diagnosis and assessment of the antifungal susceptibility of this Candida species to improve clinical management.
- Published
- 2020
- Full Text
- View/download PDF
35. In vitro inhibitory effect of statins on planktonic cells and biofilms of the Sporothrix schenckii species complex.
- Author
-
Brilhante RSN, Fonseca XMQC, Pereira VS, Araújo GDS, Oliveira JS, Garcia LGS, Rodrigues AM, Camargo ZP, Pereira-Neto WA, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, and Rocha MFG
- Subjects
- Antifungal Agents pharmacology, Microbial Sensitivity Tests, Sporothrix physiology, Biofilms drug effects, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Plankton drug effects, Sporothrix drug effects
- Abstract
Introduction. Sporotrichosis, caused by species of the Sporothrix schenckii complex, is the most prevalent subcutaneous mycosis in many areas of Latin America. Statins are a class of drugs widely used for lowering high sterol levels through their action on 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in the synthesis of sterol. Aim. In this study, the antifungal activity of statins (simvastatin, atorvastatin, pravastatin) against planktonic cells and biofilms of S. schenckii complex species was evaluated, as well as the interaction of pravastatin with classical antifungals (amphotericin B, itraconazole, terbinafine). Methodology. Eighteen strains of Sporothrix species were used. The antifungal susceptibility assay was performed using the broth microdilution method. Mature biofilms were exposed to statins and metabolic activity was measured by the XTT reduction assay. Results. MICs of statins ranged from 8 to 512 μg ml
-1 and from 8 to 256 μg ml-1 for filamentous and yeast forms, respectively. Regarding mature biofilms, MICs of 50 % inhibition (SMIC50) were 128 μg ml-1 for simvastatin and atorvastatin and >2048 μg ml-1 for pravastatin. MICs of 90 % inhibition (SMIC90) were 512 μg ml-1 for simvastatin and >2048 μg ml-1 for atorvastatin and pravastatin. Conclusion . These results highlight the antifungal and antibiofilm potential of statins against S. schenckii complex species.- Published
- 2020
- Full Text
- View/download PDF
36. Proposal for a microcosm biofilm model for the study of vulvovaginal candidiasis.
- Author
-
Cordeiro RA, de Andrade ARC, Portela FVM, Pereira LMG, Moura SGB, Sampaio MD, Pereira EMA, de Melo Guedes GM, Bandeira SP, de Lima-Neto RG, Melo VMM, Brilhante RSN, Castelo-Branco DSCM, Rocha MFG, and Sidrim JJC
- Subjects
- Candida albicans, Female, Fluconazole, Humans, Microbial Sensitivity Tests, Antifungal Agents therapeutic use, Biofilms, Candidiasis, Vulvovaginal drug therapy
- Abstract
This study proposes a microcosm biofilm (MiB) model for the study of vulvovaginal candidiasis (VVC). Different conditions that mimic the vaginal environment were tested for MiB formation. The best growth conditions were obtained with samples incubated in vaginal fluid simulator medium pH 4.5 at 35 °C under a microaerophilic atmosphere. MiBs were evaluated for growth kinetics, fluconazole susceptibility and morphology. Samples containing high numbers of bacteria were analyzed for metagenomics. At 48 h, MiBs presented a higher cell density (CFU ml
-1 ), a higher biomass and tolerance to fluconazole than their corresponding monospecies biofilms. Morphological analysis of MiBs revealed blastoconidia preferentially adhered to epithelial cells. Abundant Lactobacillus spp. were detected in two clinical samples; their MiBs showed a lower biomass and a higher fluconazole susceptibility. The proposed model proved to be a useful tool for the study of the complex microbial relationship in the vaginal environment, and may help to find new strategies for VVC control.- Published
- 2020
- Full Text
- View/download PDF
37. Antifungal activity of different molecular weight chitosans against planktonic cells and biofilm of Sporothrix brasiliensis.
- Author
-
Garcia LGS, de Melo Guedes GM, Fonseca XMQC, Pereira-Neto WA, Castelo-Branco DSCM, Sidrim JJC, de Aguiar Cordeiro R, Rocha MFG, Vieira RS, and Brilhante RSN
- Subjects
- Chitosan chemistry, Humans, Molecular Weight, Plankton drug effects, Sporothrix growth & development, Sporotrichosis drug therapy, Sporotrichosis pathology, Biofilms drug effects, Chitosan pharmacology, Sporothrix drug effects
- Abstract
Sporotrichosis, caused by Sporothrix schenckii complex species, is the most prevalent subcutaneous mycosis in many areas of Latin America. Chitosan has been used as an antifungal agent; however the effects of the molecular weight (MW) of chitosan (i.e. high (HMW), medium (MMW) and low (LMW) molecular weight chitosan) on S. brasiliensis has not been well described, particularly on biofilms. Effects on the planktonic form activity of S. brasiliensis were quantified by broth microdilution, while anti-biofilm activity was quantified by measuring metabolic activity via XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide and biomass formation (crystal violet). The molecular weight of chitosan modulated its effect on the planktonic form of S. brasiliensis, presenting lower MIC values for LMW chitosan. With regards both the adhesive and mature phases of biofilm, the LMW chitosan reduced biomass and metabolic activity most effectively. This study confirms the effects of the molecular weight and deacetylation degree of chitosan on its antifungal properties for potentially pathogenic fungi., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
38. Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin.
- Author
-
Cordeiro RA, Pereira LMG, de Sousa JK, Serpa R, Andrade ARC, Portela FVM, Evangelista AJJ, Sales JA, Aguiar ALR, Mendes PBL, Brilhante RSN, Sidrim JJDC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Cell Adhesion drug effects, Humans, Metabolism drug effects, Peptide Hydrolases analysis, Trichosporon isolation & purification, Trichosporon metabolism, Trichosporonosis microbiology, Antifungal Agents pharmacology, Biofilms drug effects, Farnesol pharmacology, Trichosporon drug effects, Trichosporon growth & development
- Abstract
Trichosporon species have been considered important agents of opportunistic systemic infections, mainly among immunocompromised patients. Infections by Trichosporon spp. are generally associated with biofilm formation in invasive medical devices. These communities are resistant to therapeutic antifungals, and therefore the search for anti-biofilm molecules is necessary. This study evaluated the inhibitory effect of farnesol against planktonic and sessile cells of clinical Trichosporon asahii (n = 3) andTrichosporon inkin (n = 7) strains. Biofilms were evaluated during adhesion, development stages and after maturation for metabolic activity, biomass and protease activity, as well as regarding morphology and ultrastructure by optical microscopy, confocal laser scanning microscopy, and scanning electron microscopy. Farnesol inhibited Trichosporon planktonic growth by 80% at concentrations ranging from 600 to 1200 μM for T. asahii and from 75 to 600 μM for T. inkin. Farnesol was able to reduce cell adhesion by 80% at 300 μM for T. asahii and T. inkin at 600 μM, while biofilm development of both species was inhibited by 80% at concentration of 150 μM, altering their structure. After biofilm maturation, farnesol decreased T. asahii biofilm formation by 50% at 600 μM concentration and T. inkin formation at 300 μM. Farnesol inhibited gradual filamentation in a concentration range between 600 and 1200 μM. Farnesol caused reduction of filament structures of Trichosporon spp. at every stage of biofilm development analyzed. These data show the potential of farnesol as an anti-biofilm molecule., (© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2019
- Full Text
- View/download PDF
39. Potassium iodide and miltefosine inhibit biofilms of Sporothrix schenckii species complex in yeast and filamentous forms.
- Author
-
Brilhante RSN, Silva MLQD, Pereira VS, de Oliveira JS, Maciel JM, Silva INGD, Garcia LGS, Guedes GMM, Cordeiro RA, Pereira-Neto WA, de Camargo ZP, Rodrigues AM, Sidrim JJC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Fungi drug effects, Kinetics, Microbial Sensitivity Tests, Microbial Viability drug effects, Microscopy, Electron, Scanning, Phosphorylcholine pharmacology, Sporothrix ultrastructure, Sporotrichosis microbiology, Antifungal Agents pharmacology, Biofilms drug effects, Biofilms growth & development, Phosphorylcholine analogs & derivatives, Potassium Iodide pharmacology, Sporothrix drug effects
- Abstract
This study aimed to evaluate the yeast biofilm growth kinetics and ultrastructure of Sporothrix schenckii complex and assess their mature biofilm susceptibility in filamentous and yeast forms to potassium iodide (KI) and miltefosine (MIL). Yeast biofilms were evaluated by crystal violet staining, XTT reduction assay and microscopic techniques. Susceptibility of planktonic and sessile cells was analyzed by broth microdilution. S. schenckii complex in yeast form produced biofilms, with an optimum maturation at 96 h, showing multilayered blastoconidia embedded in extracellular matrix. KI and MIL minimum inhibitory concentration (MIC) ranges against planktonic cells were 62,500-250,000 μg/ml and 0.125-4 μg/ml, respectively. KI and MIL reduced biofilm metabolic activity by 75.4% and 67.7% for filamentous form and 55.1% and 51.6% for yeast form, respectively. This study demonstrated that S. schenckii complex forms biofilms in vitro, and potassium iodide and miltefosine inhibit Sporothrix spp. biofilms in both filamentous and yeast forms., (© The Author(s) 2018. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2019
- Full Text
- View/download PDF
40. Sodium butyrate inhibits planktonic cells and biofilms of Trichosporon spp.
- Author
-
Cordeiro RA, Aguiar ALR, Pereira VS, Pereira LMG, Portela FVM, Brilhante RSN, Camargo ZP, Sidrim JJC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Cell Adhesion drug effects, Microbial Sensitivity Tests, Microscopy, Microscopy, Confocal, Microscopy, Electron, Scanning, Trichosporon cytology, Trichosporon growth & development, Antifungal Agents pharmacology, Biofilms drug effects, Butyric Acid pharmacology, Trichosporon drug effects
- Abstract
Trichosporon spp. have been increasingly recognized as an important pathogen of invasive and disseminated infections in immunocompromised patients. These species are prone to form biofilms in medical devices such as catheters and prosthesis, which are associated with antifungal resistance and therapeutic failure. Therefore, new antifungals with a broader anti-biofilm activity need to be discovered. In the present study we evaluate the inhibitory potential of sodium butyrate (NaBut) - a histone deacetylase inhibitor that can alter chromatin conformation - against planktonic and sessile cells of T. asahii and T. inkin. Minimum inhibitory concentration (MIC) of NaBut against planktonic cells was evaluated by microdilution and morphological changes were analyzed by optical microscopy on malt agar supplemented with NaBut. Biofilms were evaluated during adhesion, development and after maturation for metabolic activity and biomass, as well as regarding ultrastructure by scanning electron microscopy and confocal laser scanning microscopy. NaBut inhibited the growth of planktonic cells by 50% at 60 mM or 120 mM (p < 0.05) and also reduced filamentation of Trichosporon spp. NaBut reduced adhesion of Trichosporon cells by 45% (10xMIC) on average (p < 0.05). During biofilm development, NatBut (10xMIC) reduced metabolic activity and biomass up to 63% and 81%, respectively (p < 0.05). Mature biofilms were affected by NaBut (10xMIC), showing reduction of metabolic activity and biomass of approximately 48% and 77%, respectively (p < 0.05). Ultrastructure analysis showed that NaBut (MIC and 10xMIC) was able to disassemble mature biofilms. The present study describes the antifungal and anti-biofilm potential of NaBut against these opportunist emerging fungi., (Copyright © 2019. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
41. Ex vivo biofilm-forming ability of dermatophytes using dog and cat hair: an ethically viable approach for an infection model.
- Author
-
Brilhante RSN, Aguiar L, Sales JA, Araújo GDS, Pereira VS, Pereira-Neto WA, Pinheiro AQ, Paixão GC, Cordeiro RA, Sidrim JJC, Bersano PRO, Rocha MFG, and Castelo-Branco DSCM
- Subjects
- Animals, Cats, Dogs, Hyphae, Microscopy, Electron, Scanning, Seasons, Biofilms, Dermatomycoses, Hair, Microsporum physiology, Trichophyton physiology
- Abstract
The aim of this study was to establish an ex vivo model for dermatophyte biofilm growth, using hair from dogs and cats. Strains of Microsporum canis , M. gypseum , Trichophyton mentagrophytes and T. tonsurans were assessed for in vitro and ex vivo biofilm production. All T . mentagrophytes and T . tonsurans isolates and 8/12 M . canis and 1/7 M . gypseum isolates formed biofilms in vitro , while all tested isolates presented biofilm growth on ex vivo models. T. mentagrophytes and M. canis formed more homogeneous and better-structured biofilms with greater biomass production on cat hair but T. tonsurans formed more biofilm on dog hair. Confocal and scanning electron microscopy demonstrated fungal hyphae colonizing and perforating the hair shaft, abundant fungal conidia, biofilm extracellular matrix and biofilm water channels. The present study demonstrated an ex vivo model for the performance of studies on biofilm formation by dermatophytes, using dog and cat hair.
- Published
- 2019
- Full Text
- View/download PDF
42. Antifungal effects of the flavonoids kaempferol and quercetin: a possible alternative for the control of fungal biofilms.
- Author
-
Rocha MFG, Sales JA, da Rocha MG, Galdino LM, de Aguiar L, Pereira-Neto WA, de Aguiar Cordeiro R, Castelo-Branco DSCM, Sidrim JJC, and Brilhante RSN
- Subjects
- Candida drug effects, Humans, Microbial Sensitivity Tests, Antifungal Agents pharmacology, Biofilms drug effects, Kaempferols pharmacology, Quercetin pharmacology
- Abstract
This study aimed to determine the minimum inhibitory concentration (MIC) of kaempferol and quercetin against planktonic and biofilm forms of the Candida parapsilosis complex. Initially, nine C. parapsilosis sensu stricto , nine C. orthopsilosis and nine C. metapsilosis strains were used. Planktonic susceptibility to kaempferol and quercetin was assessed. Growing and mature biofilms were then exposed to the flavonoids at MIC or 10xMIC, respectively, and theywere also analyzed by confocal laser scanning microscopy. The MIC ranges were 32-128 µg ml
-1 for kaempferol and 0.5-16 µg ml-1 for quercetin. Kaempferol and quercetin decreased (P < 0.05) the metabolic activity and biomass of growing biofilms of the C . parapsilosis complex. As for mature biofilms, the metabolic effects of the flavonoids varied, according to the cryptic species, but kaempferol caused an overall reduction in biofilm biomass. Microscopic analyses showed restructuring of biofilms after flavonoid exposure. These results highlight the potential use of these compounds as sustainable resources for the control of fungal biofilms.- Published
- 2019
- Full Text
- View/download PDF
43. Exposure of Candida parapsilosis complex to agricultural azoles: An overview of the role of environmental determinants for the development of resistance.
- Author
-
Brilhante RSN, Alencar LP, Bandeira SP, Sales JA, Evangelista AJJ, Serpa R, Cordeiro RA, Pereira-Neto WA, Sidrim JJC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Agriculture, Biofilms drug effects, Biofilms growth & development, Candida parapsilosis physiology, Chlorobenzenes, Microbial Sensitivity Tests, Triazoles, Antifungal Agents toxicity, Azoles toxicity, Candida parapsilosis drug effects
- Abstract
This work investigated the phenotypic behavior of Candida parapsilosis species complex in response to exposure to agricultural azoles and fluconazole. Three fluconazole-susceptible strains of C. parapsilosis sensu stricto, C. orthopsilosis and C. metapsilosis were used. Initial minimum inhibitory concentrations (iMICs) for agricultural and clinical azoles were determined by broth microdilution. Then, the strains were exposed to tebuconazole, tetraconazole and fluconazole for 15 days, at concentrations that were two-folded daily, starting at one-eighth the iMIC (iMIC/8) up to 64 times iMIC (64xiMIC). After 15-day-exposure, antifungal susceptibility, biofilm formation, CDR, MDR and ERG expression were evaluated. The three cryptic species developed tolerance to the antifungals they were exposed and presented reduction (P < 0.05) in fluconazole susceptibility. In addition, C. parapsilosis sensu stricto and C. metapsilosis also presented reduced susceptibility to voriconazole, after fluconazole exposure. Azole exposure decreased (P < 0.05) biofilm production by C. parapsilosis sensu stricto and C. orthopsilosis and increased (P < 0.05) the expression of ERG11 in all tested strains. The results show that exposure to agricultural azoles and fluconazole induces changes in the phenotypic behavior and gene expression by the three cryptic species of C. parapsilosis complex, highlighting the importance of environmental determinants for the development of antifungal resistance., (Copyright © 2018. Published by Elsevier B.V.)
- Published
- 2019
- Full Text
- View/download PDF
44. In vitro effects of promethazine on cell morphology and structure and mitochondrial activity of azole-resistant Candida tropicalis.
- Author
-
Brilhante RSN, de Oliveira JS, de Jesus Evangelista AJ, Pereira VS, Alencar LP, Castelo-Branco DSCM, Câmara LMC, de Lima-Neto RG, Cordeiro RA, Sidrim JJC, and Rocha MFG
- Subjects
- Candida tropicalis physiology, Cell Membrane drug effects, Cell Membrane physiology, Drug Resistance, Fungal, Flow Cytometry, Humans, Membrane Potentials drug effects, Microbial Sensitivity Tests, Microbial Viability drug effects, Mitochondria metabolism, Antifungal Agents pharmacology, Biofilms drug effects, Candida tropicalis cytology, Candida tropicalis drug effects, Drug Synergism, Mitochondria drug effects, Promethazine metabolism
- Abstract
The aim of this study was to evaluate the effect of promethazine on the antifungal minimum inhibitory concentrations against planktonic cells and mature biofilms of Candida tropicalis, as well as investigate its potential mechanisms of cell damage against this yeast species. Three C. tropicalis isolates (two azole-resistant and one azole-susceptible) were evaluated for their planktonic and biofilm susceptibility to promethazine alone and in combination with itraconazole, fluconazole, voriconazole, amphotericin B, and caspofungin. The antifungal activity of promethazine against C. tropicalis was investigated by performing time-kill curve assays and assessing rhodamine 6G efflux, cell size/granularity, membrane integrity, and mitochondrial transmembrane potential, through flow cytometry. Promethazine showed antifungal activity against planktonic cells and biofilms at concentrations of 64 and 128 μg/ml, respectively. The addition of two subinhibitory concentrations of promethazine reduced the antifungal MICs for all tested azole drugs against planktonic growth, reversing the resistance phenotype to all azoles. Promethazine decreased the efflux of rhodamine 6G in an azole-resistant strain. Moreover, promethazine decreased cell size/granularity and caused membrane damage, and mitochondrial membrane depolarization. In conclusion, promethazine presented synergy with azole antifungals against resistant C. tropicalis and exhibited in vitro cytotoxicity against C. tropicalis, altering cell size/granularity, membrane integrity, and mitochondrial function, demonstrating potential mechanisms of cell damage against this yeast species.
- Published
- 2018
- Full Text
- View/download PDF
45. Phenotype-driven strategies for screening Candida parapsilosis complex for molecular identification.
- Author
-
Cordeiro RA, Sales JA, Ponte YB, Mendes PBL, Serpa R, Evangelista AJ, Alencar LP, Pereira-Neto WA, Brilhante RSN, Sidrim JJC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Candida parapsilosis classification, Candida parapsilosis genetics, Candida parapsilosis growth & development, Culture Media metabolism, Humans, Phenotype, Polymerase Chain Reaction, Candida parapsilosis isolation & purification, Candidiasis microbiology, Mycological Typing Techniques methods
- Abstract
In this study, phenotypic methods presented >80% agreement with the molecular identification of 59 Candida parapsilosis complex. Growth at 15% NaCl or pH 7.0 significantly reduced cfu-counts of Candida orthopsilosis, suggesting these conditions may support the development of phenotypic methods for the differentiation of the cryptic species of C. parapsilosis complex., (Copyright © 2018 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
46. Effect of the molecular weight of chitosan on its antifungal activity against Candida spp. in planktonic cells and biofilm.
- Author
-
Garcia LGS, Guedes GMM, da Silva MLQ, Castelo-Branco DSCM, Sidrim JJC, Cordeiro RA, Rocha MFG, Vieira RS, and Brilhante RSN
- Subjects
- Antifungal Agents chemistry, Candida physiology, Chitosan chemistry, Molecular Weight, Antifungal Agents pharmacology, Biofilms drug effects, Candida drug effects, Chitosan pharmacology, Plankton drug effects
- Abstract
Difficulties in the treatment of Candida spp. invasive infections are usually related to the formation of biofilms. The aim of this study was to determine the effects of molecular weight (MW) of chitosan (using high (HMW), medium (MMW) and low (LMW) molecular weight chitosan) on Candida albicans, Candida tropicalis and Candida parapsilosis sensu stricto. The deacetylation degree (DD) and molecular weight M were measured by potentiometric titration and viscosimetry, respectively. The planktonic shape activity was quantified by broth microdilution, and the activity against biofilm was quantified by metabolic activity through XTT 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]- 2H-tetrazolium hydroxide and biomass formation (crystal violet). The influence of chitosan MW on the planktonic form of Candida spp. was strain dependent. Fungal growth decreased with increasing chitosan MW for C. tropicalis and C. parapsilosis, while chitosan MW did not modulate the effect for C. albicans. With regard to the formation of biofilms, in both the adhesion and mature phases, the biomass and metabolic activities of Candida spp. were reduced by about 70% and 80%, respectively for each phase., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
47. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
- Author
-
Brilhante RSN, Guedes GMM, Silva MLQD, Castelo-Branco DSCM, Cordeiro RA, Sidrim JJC, and Rocha MFG
- Subjects
- Brazil, Caspofungin, HIV growth & development, HIV Infections drug therapy, HIV Infections microbiology, HIV Infections virology, Histoplasma drug effects, Histoplasma growth & development, Histoplasmosis microbiology, Histoplasmosis virology, Humans, Microbial Sensitivity Tests, Retrospective Studies, Amphotericin B pharmacology, Antifungal Agents pharmacology, Echinocandins pharmacology, Fluconazole pharmacology, Histoplasmosis drug therapy, Itraconazole pharmacology, Lipopeptides pharmacology, Voriconazole pharmacology
- Abstract
Epidemiological cut-off values (ECVs) have been used as a tool to detect the acquisition of resistance mechanisms to antifungal drugs. In this context, the objective of this study was to determine the ECVs for classic antifungals against Histoplasma capsulatum var. capsulatum isolates from human immunodeficiency virus (HIV)-infected patients with a diagnosis of disseminated histoplasmosis. First, minimum inhibitory concentrations (MICs) for amphotericin B (AmB), itraconazole (ITR), fluconazole (FLU), voriconazole (VCZ) and caspofungin (CAS) were determined against 138 H. capsulatum isolates in the filamentous form by the broth microdilution method; antifungal ECVs were then calculated. MIC ranges were 0.0078-1 µg/mL for AmB, 0.0005-0.0625 µg/mL for ITR, 2 to ≥256 µg/mL for FLU, 0.0078-1 µg/mL for VCZ and ≤0.0156 to ≥32 µg/mL for CAS. The obtained ECVs were 0.5, 0.0313, 128, 0.5 and 16 µg/mL for AmB, ITR, FLU, VCZ and CAS, respectively. The percentage of wild-type isolates was 96.4% for AmB, 98.6% for ITR and 99.3% for FLU, VCZ and CAS. Although these results do not cover all phylogenetic species of H. capsulatum, they bring important information on strains from Brazil. In addition, the assessed isolates were from HIV-positive patients, which may not reflect the antifungal ECVs against isolates from immunocompetent individuals or from other sources. Finally, this study pioneers the initiative of establishing ECVs for five antifungal agents against H. capsulatum var. capsulatum, providing a criterion for the interpretation of susceptibility results as well as a monitoring strategy for the emergence of antifungal resistance., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
48. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential.
- Author
-
Brilhante RSN, Sales JA, da Silva MLQ, de Oliveira JS, Pereira LA, Pereira-Neto WA, Cordeiro RA, Sidrim JJC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Animals, Biofilms drug effects, Caenorhabditis elegans, Candida parapsilosis enzymology, Candida parapsilosis physiology, Fungal Proteins genetics, Fungal Proteins metabolism, Humans, Peptide Hydrolases genetics, Peptide Hydrolases metabolism, Phospholipases genetics, Phospholipases metabolism, Virulence drug effects, Antifungal Agents pharmacology, Candida parapsilosis drug effects, Candida parapsilosis pathogenicity, Candidiasis microbiology
- Abstract
Purpose: Antifungal resistance and several putative virulence factors have been associated with the pathogenicity of the Candida parapsilosis species complex. The objective of this study was to evaluate the antifungal susceptibility, the production of virulence factors and the pathogenicity of the C. parapsilosis complex., Methodology: Overall, 49 isolates of C. parapsilosis sensu stricto, 19 C. orthopsilosis and nine C. metapsilosis were used. The planktonic and biofilm susceptibility to fluconazole, itraconazole, voriconazole, amphotericin B and caspofungin was assessed using a broth microdilution assay. Finally, the production of biofilm and hydrolytic enzymes and the fungal pathogenicity against Caenorhabditis elegans were investigated.Results/Key findings. Overall, one C. orthopsilosis was resistant to caspofungin and susceptible-dose-dependent to itraconazole, the other two C. orthopsilosis were susceptible-dose-dependent to fluconazole and itraconazole, and one C. metapsilosis was susceptible-dose-dependent to azoles. A total of 67.5 % of the isolates were biofilm producers. Amphotericin B and caspofungin caused the greatest reduction in the metabolic activity and biomass of mature biofilms. Phospholipase and protease production was observed in 55.1 % of C. parapsilosis sensu stricto, 42.1 % of C. orthopsilosis and 33.3 % of C. metapsilosis isolates. Moreover, 57.9 % of C. orthopsilosis and 20.4 % of C. parapsilosis sensu stricto isolates were β-haemolytic, and all C. metapsilosis were α-haemolytic. Finally, the C. parapsilosis complex caused high mortality of C. elegans after 96 h of exposure., Conclusion: These results reinforce the heterogeneity of these cryptic species for their antifungal susceptibility, virulence and pathogenic potential, emphasizing the relevance of monitoring these emerging pathogens.
- Published
- 2018
- Full Text
- View/download PDF
49. In vitro activity of azole derivatives and griseofulvin against planktonic and biofilm growth of clinical isolates of dermatophytes.
- Author
-
Brilhante RSN, Correia EEM, Guedes GMM, de Oliveira JS, Castelo-Branco DSCM, Cordeiro RA, Pinheiro AQ, Chaves LJQ, Pereira Neto WA, Sidrim JJC, and Rocha MFG
- Subjects
- Animals, Arthrodermataceae growth & development, Biofilms growth & development, Cat Diseases microbiology, Cats, Dermatomycoses microbiology, Dog Diseases microbiology, Dogs, Humans, Itraconazole pharmacology, Microbial Sensitivity Tests, Voriconazole pharmacology, Antifungal Agents pharmacology, Arthrodermataceae drug effects, Azoles pharmacology, Biofilms drug effects, Dermatomycoses veterinary, Griseofulvin pharmacology
- Abstract
As shown by recent research, most of the clinically relevant fungi, including dermatophytes, form biofilms in vitro and in vivo, which may exhibit antimicrobial tolerance that favour recurrent infections. The aim of this study was to determine the minimum inhibitory concentrations (MICs) of itraconazole (ITC), voriconazole (VCZ) and griseofulvin (GRI) against Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Microsporum canis and Microsporum gypseum in planktonic and biofilm growth. For the planktonic form, susceptibility testing was performed according to the Clinical and Laboratory Standards Institute (CLSI), document M38-A2, while biofilm susceptibility was evaluated using the XTT colorimetric essay. The planktonic growth of all strains was inhibited, with MIC values ranging from 0.00195 to 0.1225 μg/mL for VRC, 0.00195 to 0.25 μg/mL for ITC and <0.0039 to 4 μg/mL for GRI, while a 50-fold increase in the MIC was required to significantly reduce the metabolic activity (P < .05) of dermatophyte biofilms. In brief, the ability of dermatophytes to form biofilms may be a contributing factor for the recalcitrance of dermatophytoses or the dissemination of the disease., (© 2018 Blackwell Verlag GmbH.)
- Published
- 2018
- Full Text
- View/download PDF
50. Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
- Author
-
Brilhante RSN, Rocha MGD, Guedes GMM, Oliveira JS, Araújo GDS, España JDA, Sales JA, Aguiar L, Paiva MAN, Cordeiro RA, Pereira-Neto WA, Pinheiro AQ, Sidrim JJC, Castelo-Branco DSCM, and Rocha MFG
- Subjects
- Animals, Bacterial Adhesion, Biofilms drug effects, Caenorhabditis elegans, Cat Diseases microbiology, Cats, Dermatomycoses microbiology, Dog Diseases microbiology, Dogs, Epithelial Cells microbiology, Fluconazole pharmacology, Foxes microbiology, Itraconazole pharmacology, Ketoconazole pharmacology, Malassezia enzymology, Malassezia isolation & purification, Microbial Sensitivity Tests methods, Peptide Hydrolases biosynthesis, Phospholipases biosynthesis, Virulence, Antifungal Agents pharmacology, Dermatomycoses veterinary, Malassezia drug effects, Malassezia pathogenicity
- Abstract
The yeast Malassezia pachydermatis is a component of the microbiota of dogs and cats, however it can cause otitis and seborrheic dermatitis in these animals. The objective of this study was to determine the antifungal susceptibility, and evaluate virulence and pathogenicity of 25 M. pachydermatis strains from animals. Susceptibility to ketoconazole, fluconazole, itraconazole, voriconazole, terbinafine, and amphotericin B was evaluated by broth microdilution assay. In addition, biofilm-forming ability, protease, phospholipase, hemolysin and melanin production and adhesion to epithelial cells by this yeast species were assessed. Finally, strain pathogenicity was investigated using the nematode Caenorhabditis elegans. Concerning the planktonic susceptibility, minimum inhibitory concentrations varied from <0.03 to>64 μg/mL for azole derivatives, 1 to >16 μg/mL for amphotericin B and 0.03 to 0.25 μg/mL for terbinafine. All strains were classified as strong biofilm producers, and ketoconazole, fluconazole and amphotericin B presented the best inhibitory effect against mature biofilms. All fungal isolates produced proteases, whereas 14/25 strains were positive for phospholipase production. Hemolytic activity was not observed and 18/25 strains showed dark pigmentation in the presence of L-DOPA. Regarding adhesion to epithelial cells, a low adhesion rate was observed in 10/12 evaluated strains. C. elegans mortality rate reached 95.9% after 96 h of exposure of the worms to M. pachydermatis. This yeast species produces important virulence factors and presents high pathogenicity, corroborating its clinical importance., (Copyright © 2018. Published by Elsevier B.V.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.